BioSpace News Archive

Drug Development

BerGenBio Announces Start of Phase II Investigator Initiated Trial Evaluating Selective AXL Inhibitor Bemcentinib in High-risk MDS

Phase II monotherapy study of bemcentinib in high-risk MDS & AML

January 4, 2019
·
5 min read
Business

Harbour BioMed Appoints Atul Deshpande, Ph.D. MBA, Chief Strategy Officer and Head of U.S. Operations

Company also promotes Xiaoxiang Chen, MD, to Chief Development Officer, and Mai-Jing Liao, Ph.D., MBA to Chief Business Officer

January 4, 2019
·
2 min read
Business

Livongo Names Lee Shapiro Chief Financial Officer

Livongo Health today announced that it named Lee Shapiro Chief Financial Officer. Shapiro, who has been on the Board of Livongo since its founding and served as Chair of its Audit Committee, will take his new role in February 2019.

January 4, 2019
·
3 min read
Drug Development

Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan

Announces Opening of Tokyo Branch Office and Two Key Hires in Japan

January 4, 2019
·
9 min read
Deals

Global Sarcoidosis Therapeutics Market 2019-2023 | Rising Awareness about Sarcoidosis to Boost Demand | Technavio

Technavio analysts forecast the global sarcoidosis therapeutics market to have an incremental growth of $46 million during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth

January 4, 2019
·
4 min read
Job Trends

Machavert Pharmaceuticals to Present at Biotech Showcase™, 2019 in San Francisco

Machavert Pharmaceuticals announced today that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the most important week in healthcare at the Hilton San Francisco Union Square.

January 4, 2019
·
2 min read
Drug Development

Promedior Announces Pivotal Path for PRM-151 in Idiopathic Pulmonary Fibrosis Following Positive End-of-Phase 2 Meeting with FDA

Promedior, Inc., announced that it has completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to discuss the study of PRM-151, a novel investigational anti-fibrotic immunomodulator, in patients with Idiopathic Pulmonary Fibrosis (IPF)

January 4, 2019
·
6 min read
Pharm Country

CytoSorbents To Highlight Progress at Biotech Showcase 2019

CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will provide a corporate update and highlight the company’s progress at the Biotech Showcase 2019 conference on Monday, January 7, 2019 at 10:30 AM PST in San Francisco, California

January 4, 2019
·
5 min read
BioCapital

REGENXBIO to Present at the 37th Annual J.P. Morgan Healthcare Conference

REGENXBIO Inc. announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 4:30 p.m. PST at the Westin St. Francis, San Francisco

January 4, 2019
·
1 min read
Genetown

Fulcrum Therapeutics to Present at Biotech Showcase 2019

Fulcrum Therapeutics will present at next week’s Biotech Showcase in San Francisco.

January 4, 2019
·
1 min read